IRA Investing Brings More and Higher-Value Investors to InSitu Biologics Reg A+ Capital RaiseBlog
RodTurner's blog When InSitu Biologics, Inc. opened its Reg A+ pre-revenue equity offering to IRA investors in 2018, company President and CEO ... in post-operative surgical procedures. In the midst of a large Reg A+ round, Segermark ...